UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C.   20549

 

FORM 10-Q

 

(Mark one)

 

x

 

Quarterly Report Pursuant to Section 13 or 15(d) of the

 

 

 

Securities Exchange Act of 1934

 

 

 

 

 

 

 

For Quarter Ended March 31, 2008

 

 

 

 

 

 

 

or

 

 

 

 

 

o

 

Transition Report Pursuant to Section 13 or 15(d) of the

 

 

 

Securities Exchange Act of 1934

 

 

Owens-Illinois, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

1-9576

 

22-2781933

(State or other

 

(Commission

 

(IRS Employer

jurisdiction of

 

File No.)

 

Identification No.)

incorporation or

 

 

 

 

organization)

 

 

 

 

 

 

 

 

 

One Michael Owens Way, Perrysburg, Ohio

 

43551-2999

(Address of principal executive offices)

 

(Zip Code)

 

567-336-5000

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes x

 

No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer x

 

Accelerated filer o

 

 

 

Non-accelerated filer o

 

Smaller reporting company o

(Do not check if a smaller reporting company)

 

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

 

Yes o

 

No x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Owens-Illinois, Inc. $.01 par value common stock – 166,729,329 shares at March 31, 2008.

 

 



 

Part I – FINANCIAL INFORMATION

 

Item 1.  Financial Statements.

 

The Condensed Consolidated Financial Statements presented herein are unaudited but, in the opinion of management, reflect all adjustments necessary to present fairly such information for the periods and at the dates indicated.  All adjustments are of a normal recurring nature. Because the following unaudited condensed consolidated financial statements have been prepared in accordance with Article 10 of Regulation S-X, they do not contain all information and footnotes normally contained in annual consolidated financial statements; accordingly, they should be read in conjunction with the Consolidated Financial Statements and notes thereto appearing in the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2007.

 

On July 31, 2007, the Company completed the sale of its plastics packaging business to Rexam PLC.  As required by Statement of Financial Accounting Standards (“FAS”) No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” the Company has presented the results of operations for the plastics packaging business in the Condensed Consolidated Results of Operations for the three month period ended March 31, 2007 as a discontinued operation.  As such, results for that period have been reclassified to conform to this presentation.  At March 31, 2007, the assets and liabilities of the plastics packaging business are presented in the Condensed Consolidated Balance Sheet as the assets and liabilities of discontinued operations.

 

The format of the Company’s 2007 condensed consolidated income statement has been reclassified to conform with the presentation used in the current period.

 

2



 

OWENS-ILLINOIS, INC.

CONDENSED CONSOLIDATED RESULTS OF OPERATIONS

 (Dollars in millions, except per share amounts)

 

 

 

Three months ended March 31,

 

 

 

2008

 

2007

 

Net sales

 

$

1,960.5

 

$

1,684.0

 

Manufacturing, shipping, and delivery

 

(1,503.7

)

(1,356.2

)

 

 

 

 

 

 

Gross profit

 

456.8

 

327.8

 

 

 

 

 

 

 

Selling and administrative expense

 

(127.8

)

(127.2

)

Research, development, and engineering expense

 

(16.0

)

(14.7

)

Interest expense

 

(64.3

)

(81.0

)

Interest income

 

8.7

 

3.4

 

Equity earnings

 

11.1

 

5.1

 

Royalties and net technical assistance

 

4.8

 

4.9

 

Other income

 

1.8

 

3.6

 

Other expense

 

(20.0

)

(16.5

)

 

 

 

 

 

 

Earnings from continuing operations before items below

 

255.1

 

105.4

 

 

 

 

 

 

 

Provision for income taxes

 

(64.9

)

(38.6

)

Minority share owners’ interests in earnings of subsidiaries

 

(16.2

)

(11.5

)

 

 

 

 

 

 

Earnings from continuing operations

 

174.0

 

55.3

 

Net losses of discontinued operations

 

 

 

(2.1

)

Gain on sale of discontinued operations

 

4.1

 

 

 

 

 

 

 

 

 

Net earnings

 

$

178.1

 

$

53.2

 

 

 

 

 

 

 

Convertible preferred stock dividends

 

(5.4

)

(5.4

)

Earnings available to common share owners

 

$

172.7

 

$

47.8

 

 

 

 

 

 

 

Basic net earnings per share of common stock:

 

 

 

 

 

Earnings from continuing operations

 

$

1.08

 

$

0.32

 

Net losses of discontinued operations

 

 

 

(0.01

)

Gain on sale of discontinued operations

 

0.03

 

 

 

 

 

 

 

 

 

Net earnings

 

$

1.11

 

$

0.31

 

 

 

 

 

 

 

Weighted average shares outstanding (thousands)

 

156,324

 

152,936

 

 

 

 

 

 

 

Diluted net earnings per share of common stock:

 

 

 

 

 

Earnings from continuing operations

 

$

1.02

 

$

0.31

 

Net losses of discontinued operations

 

 

 

(0.01

)

Gain on sale of discontinued operations

 

0.02

 

 

 

 

 

 

 

 

 

Net earnings

 

$

1.04

 

$

0.30

 

 

 

 

 

 

 

Weighted diluted average shares (thousands)

 

170,517

 

156,993

 

 

See accompanying notes.

 

3



 

OWENS-ILLINOIS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 (Dollars in millions, except per share amounts)

 

 

 

March 31,

 

Dec. 31,

 

March 31,

 

 

 

2008

 

2007

 

2007

 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

483.0

 

$

387.7

 

$

293.7

 

Short-term investments, at cost which approximates market

 

51.7

 

59.8

 

49.8

 

Receivables, less allowances for losses and discounts ($35.5 at March 31, 2008, $36.0 at December 31, 2007, and $34.1 at March 31, 2007)

 

1,320.6

 

1,185.6

 

1,130.9

 

Inventories

 

1,222.4

 

1,020.8

 

1,072.5

 

Prepaid expenses

 

37.1

 

40.7

 

34.7

 

Assets of discontinued operations

 

 

 

 

 

122.7

 

 

 

 

 

 

 

 

 

Total current assets

 

3,114.8

 

2,694.6

 

2,704.3

 

 

 

 

 

 

 

 

 

Investments and other assets:

 

 

 

 

 

 

 

Equity investments

 

87.4

 

81.0

 

92.5

 

Repair parts inventories

 

157.0

 

155.8

 

145.1

 

Prepaid pension

 

591.4

 

566.4

 

505.9

 

Deposits, receivables, and other assets

 

489.4

 

448.7

 

459.3

 

Goodwill

 

2,522.2

 

2,428.1

 

2,276.0

 

Assets of discontinued operations

 

 

 

 

 

582.2

 

 

 

 

 

 

 

 

 

Total other assets

 

3,847.4

 

3,680.0

 

4,061.0

 

 

 

 

 

 

 

 

 

Property, plant, and equipment, at cost

 

6,707.0

 

6,423.1

 

5,881.4

 

Less accumulated depreciation

 

3,711.8

 

3,473.1

 

3,047.3

 

 

 

 

 

 

 

 

 

Net property, plant, and equipment

 

2,995.2

 

2,950.0

 

2,834.1

 

 

 

 

 

 

 

 

 

Total assets

 

$

9,957.4

 

$

9,324.6

 

$

9,599.4

 

 

4



 

CONDENSED CONSOLIDATED BALANCE SHEETS – Continued

 

 

 

March 31,

 

Dec. 31,

 

March 31,

 

 

 

2008

 

2007

 

2007

 

Liabilities and Share Owners’ Equity

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Short-term loans and long-term debt due within one year

 

$

835.1

 

$

700.9

 

$

550.4

 

Current portion of asbestos-related liabilities

 

210.0

 

210.0

 

149.0

 

Accounts payable

 

978.5

 

957.5

 

842.9

 

Other liabilities

 

656.9

 

661.1

 

549.7

 

Liabilities of discontinued operations

 

 

 

 

 

75.0

 

Total current liabilities

 

2,680.5

 

2,529.5

 

2,167.0

 

 

 

 

 

 

 

 

 

Liabilities of discontinued operations

 

 

 

 

 

8.2

 

Long-term debt

 

3,192.5

 

3,013.5

 

5,103.4

 

Deferred taxes

 

128.8

 

109.4

 

122.8

 

Pension benefits

 

314.4

 

313.7

 

340.4

 

Nonpension postretirement benefits

 

279.6

 

287.0

 

289.9

 

Other liabilities

 

409.1

 

386.9

 

370.8

 

Asbestos-related liabilities

 

205.3

 

245.5

 

497.7

 

Commitments and contingencies

 

 

 

 

 

 

 

Minority share owners’ interests

 

248.4

 

251.7

 

209.8

 

Share owners’ equity:

 

 

 

 

 

 

 

Convertible preferred stock, par value

 

 

 

452.5

 

452.5

 

Common stock, par value $.01 per share 250,000,000 shares authorized, 178,413,409 shares issued and outstanding, less 11,684,080 treasury shares at March 31, 2008 (169,063,219 issued and outstanding, less 11,712,278 treasury shares at December 31, 2007 and 166,603,721 issued and outstanding, less 11,833,946 treasury shares at March 31, 2007)

 

1.8

 

1.7

 

1.7

 

Capital in excess of par value

 

2,887.7

 

2,420.0

 

2,340.1

 

Treasury stock, at cost

 

(224.0

)

(224.6

)

(226.9

)

Retained earnings (deficit)

 

(112.6

)

(285.3

)

(1,556.6

)

Accumulated other comprehensive loss

 

(54.1

)

(176.9

)

(521.4

)

Total share owners’ equity

 

2,498.8

 

2,187.4

 

489.4

 

Total liabilities and share owners’ equity

 

$

9,957.4

 

$

9,324.6

 

$

9,599.4

 

 

See accompanying notes.

 

5



 

OWENS-ILLINOIS, INC.

CONDENSED CONSOLIDATED CASH FLOWS

 (Dollars in millions)

 

 

 

Three months ended March 31,

 

 

 

2008

 

2007

 

Cash flows from operating activities:

 

 

 

 

 

Net earnings

 

$

178.1

 

$

53.2

 

Net loss of discontinued operations

 

 

 

2.1

 

Gain on sale of discontinued operations

 

(4.1

)

 

 

Non-cash charges (credits):

 

 

 

 

 

Depreciation

 

113.6

 

100.1

 

Amortization of intangibles and other deferred items

 

7.6

 

5.4

 

Amortization of finance fees

 

1.9

 

1.9

 

Deferred tax provision

 

(1.7

)

12.1

 

Restructuring and asset impairment

 

12.9

 

 

 

Other

 

(9.4

)

12.1

 

Asbestos-related payments

 

(40.2

)

(41.0

)

Change in non-current operating assets

 

(0.8

)

9.2

 

Change in non-current liabilities

 

(20.4

)

(22.8

)

Change in components of working capital

 

(216.8

)

(172.5

)

Cash provided by (utilized in) continuing operating activities

 

20.7

 

(40.2

)

Cash utilized in discontinued operating activities

 

 

 

(3.9

)

Cash flows from investing activities:

 

 

 

 

 

Additions to property, plant, and equipment - continuing

 

(45.4

)

(32.6

)

Additions to property, plant, and equipment - discontinued

 

 

 

(8.8

)

Advance to equity affiliate

 

(15.0

)

 

 

Acquisitions, net of cash acquired

 

 

 

(6.3

)

Net cash proceeds (payments) related to divestitures and asset sales

 

(16.6

)

1.6

 

Cash utilized in investing activities

 

(77.0

)

(46.1

)

Cash flows from financing activities:

 

 

 

 

 

Additions to long-term debt

 

309.2

 

401.7

 

Repayments of long-term debt

 

(222.6

)

(63.3

)

Increase (decrease) in short-term loans

 

82.3

 

(174.2

)

Net payments for hedging activity

 

(33.9

)

(1.6

)

Payment of finance fees

 

 

 

(6.3

)

Convertible preferred stock dividends

 

(5.4

)

(5.4

)

Issuance of common stock and other

 

9.8

 

6.3

 

Cash provided by financing activities

 

139.4

 

157.2

 

Effect of exchange rate fluctuations on cash

 

12.2

 

4.0

 

Increase in cash

 

95.3

 

71.0

 

Cash at beginning of period

 

387.7

 

222.7

 

Cash at end of period

 

$

483.0

 

$

293.7

 

 

See accompanying notes.

 

6



 

OWENS-ILLINOIS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Tabular data dollars in millions,

except share and per share amounts

 

1.              Earnings Per Share

 

The following table sets forth the computation of basic and diluted earnings per share:

 

 

 

Three months ended March 31,

 

 

 

2008

 

2007

 

Numerator:

 

 

 

 

 

Net earnings

 

$

178.1

 

$

53.2

 

Convertible preferred stock dividends

 

(5.4

)

(5.4

)

Numerator for basic earnings per share - income available to common share owners

 

$

172.7

 

$

47.8

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

Denominator for basic earnings per share - weighted average shares outstanding

 

156,324,072

 

152,936,438

 

Effect of dilutive securities:

 

 

 

 

 

Convertible preferred stock

 

8,589,355

 

 

 

Stock options and other

 

5,603,451

 

4,056,634

 

Denominator for diluted earnings per share - adjusted weighted average shares outstanding

 

170,516,878

 

156,993,072

 

 

 

 

 

 

 

Basic earnings per share:

 

 

 

 

 

Earnings from continuing operations

 

$

1.08

 

$

0.32

 

Net earnings of discontinued operations

 

 

 

(0.01

)

Gain on sale of discontinued operations

 

0.03

 

 

 

Net earnings

 

$

1.11

 

$

0.31

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

Earnings from continuing operations

 

$

1.02

 

$

0.31

 

Net earnings of discontinued operations

 

 

 

(0.01

)

Gain on sale of discontinued operations

 

0.02

 

 

 

Net earnings

 

$

1.04

 

$

0.30

 

 

The convertible preferred stock was included in the computation of diluted earnings per share for the three months ended March 31, 2008 on an “if converted” basis since the result was dilutive. For purposes of this computation, the preferred stock dividends were not subtracted from the numerator.  The convertible preferred stock was not included in the computation of diluted earnings per share for the three months ended March 31, 2007 since the result would have been antidilutive.  Options to purchase 2,213,671 weighted average shares of common stock that were outstanding during the three months ended March 31, 2007 were not included in

 

7



 

the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares.

 

2.              Debt

 

The following table summarizes the long-term debt of the Company:

 

 

 

March 31,

 

Dec. 31,

 

March 31,

 

 

 

2008

 

2007

 

2007

 

Secured Credit Agreement:

 

 

 

 

 

 

 

Revolving Credit Facility:

 

 

 

 

 

 

 

Revolving Loans

 

$

86.8

 

$

 

$

4.1

 

Term Loans:

 

 

 

 

 

 

 

Term Loan A (225.0 million AUD at March 31, 2008)

 

206.1

 

198.1

 

236.3

 

Term Loan B

 

191.5

 

191.5

 

195.5

 

Term Loan C (110.8 million CAD at March 31, 2008)

 

108.3

 

113.2

 

116.2

 

Term Loan D (€191.5 million at March 31, 2008)

 

302.1

 

281.8

 

260.9

 

Senior Secured Notes:

 

 

 

 

 

 

 

8.875%, due 2009

 

 

 

 

 

850.0

 

7.75%, due 2011

 

 

 

 

 

450.0

 

8.75%, due 2012

 

 

 

 

 

625.0

 

Senior Notes:

 

 

 

 

 

 

 

8.10%, due 2007

 

 

 

 

 

299.4

 

7.35%, due 2008

 

250.4

 

249.8

 

246.8

 

8.25%, due 2013

 

461.8

 

450.6

 

435.8

 

6.75%, due 2014

 

400.0

 

400.0

 

400.0

 

6.75%, due 2014 (€225 million)

 

355.0

 

331.1

 

300.3

 

6.875%, due 2017 (€300 million)

 

473.3

 

441.5

 

400.4

 

Senior Debentures:

 

 

 

 

 

 

 

7.50%, due 2010

 

258.5

 

253.0

 

245.5

 

7.80%, due 2018

 

250.0

 

250.0

 

250.0

 

Other

 

122.1

 

118.2

 

95.2

 

Total long-term debt

 

3,465.9

 

3,278.8

 

5,411.4

 

Less amounts due within one year

 

273.4

 

265.3

 

308.0

 

Long-term debt

 

$

3,192.5

 

$

3,013.5

 

$

5,103.4

 

 

On June 14, 2006, the Company’s subsidiary borrowers entered into the Secured Credit Agreement (the “Agreement”).  At March 31, 2008, the Agreement included a $900.0 million revolving credit facility, a 225.0 million Australian dollar term loan, and a 110.8 million Canadian dollar term loan, each of which has a final maturity date of June 15, 2012. It also included a $191.5 million term loan and a €191.5 million term loan, each of which has a final maturity date of June 14, 2013.

 

At March 31, 2008 the Company’s subsidiary borrowers had unused credit of $725.6 million available under the Agreement.

 

The weighted average interest rate on borrowings outstanding under the Agreement at March 31, 2008 was 6.08%.

 

During March 2007, a subsidiary of the Company issued Senior Notes totaling €300.0 million.  The notes bear interest at 6.875% and are due March 31, 2017.  The notes are guaranteed by substantially all of the Company’s domestic subsidiaries.  The proceeds were used to retire the $300 million principal amount of 8.10% Senior Notes which matured in May 2007, and to reduce borrowings under the revolving credit facility.

 

8



 

The $250 million principal amount of the 7.35% senior notes will mature on May 15, 2008.  The Company will utilize borrowings under the revolving credit facility to fund the retirement of the notes.

 

Information related to the Company’s accounts receivable securitization program is as follows:

 

 

 

March 31,

 

Dec. 31,

 

March 31,

 

 

 

2008

 

2007

 

2007

 

 

 

 

 

 

 

 

 

Balance (included in short-term loans)

 

$

439.6

 

$

361.8

 

$

229.2

 

 

 

 

 

 

 

 

 

Weighted average interest rate

 

6.10

%

5.48

%

5.61

%

 

3.  Supplemental Cash Flow Information

 

 

 

Three months ended March 31,

 

 

 

2008

 

2007

 

 

 

 

 

 

 

Interest paid in cash

 

$

40.4

 

$

60.6

 

 

 

 

 

 

 

Income taxes paid in cash

 

25.3

 

33.2

 

 

4.  Comprehensive Income

 

The components of comprehensive income are: (a) net earnings; (b) change in fair value of certain derivative instruments; (c) pension and other postretirement benefit adjustments; and (d) foreign currency translation adjustments.  Total comprehensive income is as follows:

 

 

 

Three months ended
March 31,

 

 

 

2008

 

2007

 

 

 

 

 

 

 

Net earnings

 

$

178.1

 

$

53.2

 

Foreign currency translation adjustments

 

91.3

 

36.3

 

Pension and other postretirement benefit adjustments

 

8.3

 

11.8

 

Change in fair value of derivative instruments, net of tax

 

23.2

 

24.7

 

Total comprehensive income

 

$

300.9

 

$

126.0

 

 

For the three months ended March 31, 2008, foreign currency translation adjustments includes a loss of approximately $24.2 million related to a hedge of the Company’s net investment in a non-U.S. subsidiary.

 

5.  Inventories

 

Major classes of inventory are as follows:

 

9



 

 

 

March 31,

 

Dec. 31,

 

March 31,

 

 

 

2008

 

2007

 

2007

 

Finished goods

 

$

1,050.8

 

$

861.1

 

$

897.7

 

Work in process

 

1.9

 

1.4

 

3.5

 

Raw materials

 

100.4

 

90.5

 

105.2

 

Operating supplies

 

69.3

 

67.8

 

66.1

 

 

 

 

 

 

 

 

 

 

 

$

1,222.4

 

$

1,020.8

 

$

1,072.5

 

 

6.  Contingencies

 

The Company is one of a number of defendants in a substantial number of lawsuits filed in numerous state and federal courts by persons alleging bodily injury (including death) as a result of exposure to dust from asbestos fibers.  From 1948 to 1958, one of the Company’s former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material containing asbestos.  The Company exited the pipe and block insulation business in April 1958.  The traditional asbestos personal injury lawsuits and claims relating to such production and sale of asbestos material typically allege various theories of liability, including negligence, gross negligence and strict liability and seek compensatory and in some cases, punitive damages in various amounts (herein referred to as “asbestos claims”).

 

As of March 31, 2008, the Company has determined that it is a named defendant in asbestos lawsuits and claims involving approximately 14,000 plaintiffs and claimants.  Based on an analysis of the lawsuits pending as of December 31, 2007, approximately 89% of plaintiffs either do not specify the monetary damages sought, or in the case of court filings, claim an amount sufficient to invoke the jurisdictional minimum of the trial court.  Approximately 9% of plaintiffs specifically plead damages of $15 million or less, and 1% of plaintiffs specifically plead damages greater than $15 million but less than $100 million.  Fewer than 1% of plaintiffs specifically plead damages $100 million or greater but less than $123 million.

 

As indicated by the foregoing summary, current pleading practice permits considerable variation in the assertion of monetary damages.  The Company’s experience resolving hundreds of thousands of asbestos claims and lawsuits over an extended period demonstrates that the monetary relief which may be alleged in a complaint bears little relevance to a claim’s merits or disposition value.  Rather, the amount potentially recoverable is determined by such factors as the plaintiff’s severity of disease, the product identification evidence against specific defendants, the defenses available to those defendants, the specific jurisdiction in which the claim is made, and the plaintiff’s history of smoking or exposure to other possible disease-causative factors.

 

In addition to the pending claims set forth above, the Company has claims-handling agreements in place with many plaintiffs’ counsel throughout the country.  These agreements require evaluation and negotiation regarding whether particular claimants qualify under the criteria established by such agreements. The criteria for such claims include verification of a compensable illness and a reasonable probability of exposure to a product manufactured by the Company’s former business unit during its manufacturing period ending in 1958.  Some plaintiffs’ counsel have historically withheld claims under these agreements for later presentation while focusing their attention on active litigation in the tort system.  The Company believes that as of March 31, 2008 there are approximately 1,100 claims against other

 

10



 

defendants which are likely to be asserted some time in the future against the Company. These claims are not included in the pending “lawsuits and claims” totals set forth above.

 

The Company is also a defendant in other asbestos-related lawsuits or claims involving maritime workers, medical monitoring claimants, co-defendants and property damage claimants.  Based upon its past experience, the Company believes that these categories of lawsuits and claims will not involve any material liability and they are not included in the above description of pending matters or in the following description of disposed matters.

 

Since receiving its first asbestos claim, the Company as of March 31, 2008, has disposed of the asbestos claims of approximately 361,000 plaintiffs and claimants at an average indemnity payment per claim of approximately $7,000.  Certain of these dispositions have included deferred amounts payable over a number of years.  Deferred amounts payable totaled approximately $31.8 million at March 31, 2008 ($34.0 million at December 31, 2007) and are included in the foregoing average indemnity payment per claim.  The Company’s indemnity payments for these claims have varied on a per claim basis, and are expected to continue to vary considerably over time.  As discussed above, a part of the Company’s objective is to achieve, where possible, resolution of asbestos claims pursuant to claims-handling agreements.  Failure of claimants to meet certain medical and product exposure criteria in the Company’s administrative claims handling agreements has generally reduced the number of marginal or suspect claims that would otherwise have been received. This may have the effect of increasing the Company’s per-claim average indemnity payment over time.

 

The Company believes that its ultimate asbestos-related liability (i.e., its indemnity payments or other claim disposition costs plus related legal fees) cannot be estimated with certainty. Beginning with the initial liability of $975 million established in 1993, the Company has accrued a total of approximately $3.22 billion through 2007, before insurance recoveries, for its asbestos-related liability.  The Company’s ability reasonably to estimate its liability has been significantly affected by the volatility of asbestos-related litigation in the United States, the expanding list of non-traditional defendants that have been sued in this litigation and found liable for substantial damage awards, the use of mass litigation screenings to generate new lawsuits, the large number of claims asserted or filed by parties who claim prior exposure to asbestos materials but have no present physical impairment as a result of such exposure, and the significant number of co-defendants that have filed for bankruptcy.

 

The Company has continued to monitor trends which may affect its ultimate liability and has continued to analyze the developments and variables affecting or likely to affect the resolution of pending and future asbestos claims against the Company. The material components of the Company’s accrued liability are based on amounts estimated by the Company in connection with its annual comprehensive review and consist of the following: (i) the reasonably probable contingent liability for asbestos claims already asserted against the Company; (ii) the contingent liability for preexisting but unasserted asbestos claims for prior periods arising under its administrative claims-handling agreements with various plaintiffs’ counsel; (iii) the contingent liability for asbestos claims not yet asserted against the Company, but which the Company believes it is reasonably probable will be asserted in the next several years, to the degree that an estimation as to future claims is possible, and (iv) the legal defense costs likely to be incurred in connection with the foregoing types of claims.

 

The significant assumptions underlying the material components of the Company’s accrual concern:

 

11



 

a)   the extent to which settlements are limited to claimants who were exposed to the Company’s asbestos-containing insulation prior to its exit from that business in 1958;

 

b)   the extent to which claims are resolved under the Company’s administrative claims agreements or on terms comparable to those set forth in those agreements;

 

c)   the extent to which the Company’s accelerated settlements in 2007 impact the number and type of future claims and lawsuits;

 

d)   the extent of decrease or increase in the inventory of pending serious disease cases;

 

e)   the extent to which the Company is able to defend itself successfully at trial;

 

f)   the extent to which courts and legislatures eliminate, reduce or permit the diversion of financial resources for unimpaired claimants and so-called forum shopping;

 

g)   the extent to which additional defendants with substantial resources and assets are required to participate significantly in the resolution of future asbestos lawsuits and claims;

 

h)   the number and timing of co-defendant bankruptcies; and

 

i)   the extent to which the resolution of co-defendant bankruptcies direct resources to resolve claims that are also presented to the Company.

 

As noted above, the Company conducts a comprehensive review of its asbestos-related liabilities and costs annually in connection with finalizing and reporting its annual results of operations, unless significant changes in trends or new developments warrant an earlier review.  If the results of an annual comprehensive review indicate that the existing amount of the accrued liability is insufficient to cover its estimated future asbestos-related costs, then the Company will record an appropriate charge to increase the accrued liability.  The Company believes that an estimation of the reasonably probable amount of the contingent liability for claims not yet asserted against the Company is not possible beyond a period of several years.  Therefore, while the results of future annual comprehensive reviews cannot be determined, the Company expects the addition of one year to the estimation period will result in an annual charge.

 

Other litigation is pending against the Company, in many cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief.  In accordance with FAS No. 5, the Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated.  Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based including additional information, negotiations, settlements, and other events.

 

The ultimate legal and financial liability of the Company with respect to the lawsuits and proceedings referred to above, in addition to other pending litigation, cannot be estimated with certainty.  The Company’s reported results of operations for 2007 were materially affected by the $115.0 million fourth quarter charge for asbestos-related costs and asbestos-related payments continue to be substantial.  Any future additional charge would likewise materially affect the Company’s results of operations for the period in which it is recorded. Also, the

 

12



 

continued use of significant amounts of cash for asbestos-related costs has affected and will continue to affect the Company’s cost of borrowing and its ability to pursue global or domestic acquisitions. However, the Company believes that its operating cash flows and other sources of liquidity will be sufficient to pay its obligations for asbestos-related costs and to fund its working capital and capital expenditure requirements on a short-term and long-term basis.

 

7. Segment Information

 

The Company’s former Plastics Packaging segment has been reclassified to discontinued operations for 2007 as a result of the July 31, 2007 sale of that business.  Following the sale, the Company redefined its reportable segments and divided the former Glass Containers segment into four geographic segments:  (1) North America; (2) Europe; (3) Asia Pacific; (4) South America.  These four segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations.  In connection with this change, certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained Corporate Costs and Other.  These include licensing, equipment manufacturing, global engineering, and non-glass equity investments.  Amounts for 2007 in the following tables are presented on the redefined basis.

 

The Company’s measure of profit for its reportable segments is Segment Operating Profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, provision for income taxes and minority share owners’ interests in earnings of subsidiaries and excludes amounts related to certain items that management considers not representative of ongoing operations.  The Company’s management uses Segment Operating Profit, in combination with gross profit percentage and selected cash flow information, to evaluate performance and to allocate resources.

 

Segment Operating Profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided.  Beginning in 2008, the Company revised its method of allocating corporate expenses.  The Company decreased slightly the percentage allocation based on sales and significantly expanded the number of functions included in the allocation based on cost of services. It is not practicable to quantify the net effect of these changes on periods prior to 2008. However, the effect for 2008 was to reduce the amount of retained corporate costs by approximately $8 million.  The information below is presented on a continuing operations basis, and therefore, the 2007 amounts exclude amounts related to the discontinued operations.   See Note 14 for more information.

 

Financial information for the three month periods ended March 31, 2008 and 2007 regarding the Company’s reportable segments is as follows:

 

 

 

2008

 

2007

 

Net Sales:

 

 

 

 

 

Europe

 

$

888.9

 

$

728.4

 

North America

 

530.9

 

523.4

 

South America

 

254.2

 

203.2

 

Asia Pacific

 

250.0

 

212.5

 

Reportable segment totals

 

1,924.0

 

1,667.5

 

Other

 

36.5

 

16.5

 

Consolidated totals

 

$

1,960.5

 

$

1,684.0

 

 

13



 

 

 

2008

 

2007

 

Segment Operating Profit:

 

 

 

 

 

Europe

 

$

147.6

 

$

74.8

 

North America

 

55.5

 

62.5

 

South America

 

73.6

 

48.0

 

Asia Pacific

 

45.4

 

24.7

 

Reportable segment totals

 

322.1

 

210.0

 

Retained corporate costs and other

 

1.5

 

(27.0

)

Consolidated totals

 

323.6

 

183.0

 

 

 

 

 

 

 

Reconciliation to earnings from continuing operations before income taxes and minority share owners’ interest in earnings of subsidiaries:

 

 

 

 

 

 

 

 

 

 

 

Items excluded from Segment Operating Profit:

 

 

 

 

 

Restructuring and asset impairment

 

(12.9

)

 

 

Interest income

 

8.7

 

3.4

 

Interest expense

 

(64.3

)

(81.0

)

Total

 

$

255.1

 

$

105.4

 

 

Financial information regarding the Company’s total assets is as follows:

 

 

 

March 31,

 

Dec. 31,

 

March 31,

 

 

 

2008

 

2007

 

2007

 

Total assets (1):

 

 

 

 

 

 

 

Europe

 

$

4,425.3

 

$

4,124.1

 

$

3,911.1

 

North America

 

2,016.2

 

1,946.9

 

1,823.2

 

South America

 

974.5

 

965.7

 

800.3

 

Asia Pacific

 

1,617.5

 

1,558.1

 

1,483.5

 

Reportable segment totals

 

9,033.5

 

8,594.8

 

8,018.1

 

Other

 

923.9

 

729.8

 

1,581.3

 

Consolidated totals

 

$

9,957.4

 

$

9,324.6

 

$

9,599.4

 

 


(1) Retained Corporate Costs and Other includes assets of discontinued operations.

 

8. Other Costs and Expenses

 

During the first quarter of 2008, the Company recorded charges totaling $12.9 million ($9.7 million after tax), for additional restructuring and asset impairment in the Caribbean, Asia Pacific, Europe, and North America.  The charges reflect the additional results of the Company’s ongoing global profitability review.  See Note 10 for additional information.

 

9. Derivative Instruments

 

At March 31, 2008, the Company had the following derivative instruments related to its various hedging programs:

 

Interest Rate Swaps Designated as Fair Value Hedges

 

In the fourth quarter of 2003 and the first quarter of 2004, the Company entered into a series of interest rate swap agreements with a current total notional amount of $950 million that mature from 2008 through 2013.  The swaps were executed in order to: (i) convert a portion of the senior notes and senior debentures fixed-rate debt into floating-rate debt; (ii) maintain a capital

 

14



 

structure containing appropriate amounts of fixed and floating-rate debt; and (iii) reduce net interest payments and expense in the near-term.

 

The Company’s fixed-to-variable interest rate swaps are accounted for as fair value hedges.  Because the relevant terms of the swap agreements match the corresponding terms of the notes, there is no hedge ineffectiveness. Accordingly, the Company recorded the net of the fair market values of the swaps as a long-term asset (liability) along with a corresponding net increase (decrease) in the carrying value of the hedged debt.

 

Under the swaps, the Company receives fixed rate interest amounts (equal to interest on the corresponding hedged note) and pays interest at a six-month U.S. LIBOR rate (set in arrears) plus a margin spread (see table below).  The interest rate differential on each swap is recognized as an adjustment of interest expense during each six-month period over the term of the agreement.

 

The following selected information relates to fair value swaps at March 31, 2008:

 

 

 

 

 

 

 

 

 

Asset

 

 

 

Amount

 

Receive

 

Average

 

(Liability)

 

 

 

Hedged

 

Rate

 

Spread

 

Recorded

 

 

 

 

 

 

 

 

 

 

 

Senior Notes due 2008

 

$

250.0

 

7.35

%

3.5

%

$

0.4

 

Senior Debentures due 2010

 

250.0

 

7.50

%

3.2

%

8.5

 

Senior Notes due 2013

 

450.0

 

8.25

%

3.7

%

11.8

 

Total

 

$

950.0

 

 

 

 

 

$

20.7

 

 

Commodity Hedges

 

The Company enters into commodity futures contracts related to forecasted natural gas requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for natural gas and the related volatility in cash flows.  The Company continually evaluates the natural gas market with respect to its forecasted usage requirements over the next twelve to eighteen months and periodically enters into commodity futures contracts in order to hedge a portion of its usage requirements over that period.  At March 31, 2008, the Company had entered into commodity futures contracts for approximately 48% (approximately 8,320,000 MM BTUs) of its estimated North American usage requirements for the last three quarters of 2008 and approximately 8% (approximately 1,920,000 MM BTUs) for the full year 2009.

 

The Company accounts for the above futures contracts on the balance sheet at fair value.  The effective portion of changes in the fair value of a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified into earnings in the same period or periods during which the underlying hedged item affects earnings.  Any material portion of the change in the fair value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current earnings.

 

The above futures contracts are accounted for as cash flow hedges at March 31, 2008.

 

15



 

At March 31, 2008, an unrecognized gain of $18.7 million (pretax and after tax), related to the domestic commodity futures contracts, was included in OCI, which will be reclassified into earnings over the next twelve months.  The ineffectiveness related to these natural gas hedges for the three months ended March 31, 2008 was not material.

 

Other Hedges

 

The Company’s subsidiaries may enter into short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future.  These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency.   Subsidiaries may also use forward exchange agreements to offset the foreign currency risk for receivables and payables not denominated in, or indexed to, their functional currencies.  The Company records these short-term forward exchange agreements on the balance sheet at fair value and changes in the fair value are recognized in current earnings.

 

Balance Sheet Classification

 

The Company records the fair values of derivative financial instruments on the balance sheet as follows: (1) receivables if the instrument has a positive fair value and maturity within one year, (2) deposits, receivables, and other assets if the instrument has a positive fair value and maturity after one year, (3) accounts payable and other current liabilities if the instrument has a negative fair value and maturity within one year, and (4) other liabilities if the instrument has a negative fair value and maturity after one year.

 

10.  Restructuring Accruals

 

During the third and fourth quarters of 2007, the Company recorded charges totaling $100.3 million ($84.1 million after tax), for restructuring and asset impairment in the Caribbean, Europe, and North America. The Company recorded additional charges of $12.9 million ($9.7 million after tax) in the first quarter of 2008 for restructuring and asset impairment in the Caribbean, Asia-Pacific, Europe, and North America. These charges, amounting to $113.2 million, reflect the initial conclusions of the Company’s global profitability review commenced in mid-2007.

 

Equity Investment

 

In the Company’s 50%-owned affiliate in the Caribbean, declining productivity and cash flows resulted in impairment of the Company’s equity investment, establishment of valuation allowances against advances to the affiliate, and accrual of certain contingent obligations for total charges of $45.0 million recorded in 2007 with an additional $0.9 million recorded in the first quarter of 2008.

 

Production Capacity

 

In Europe, North America, and Asia Pacific, the Company decided to curtail selected production capacity.  Because the future undiscounted cash flows of the related asset groups were not sufficient to recover their carrying amounts, the assets were considered impaired.  As a result the assets were written down to the extent their carrying amounts exceeded fair value.  The curtailment of plant capacity resulted in elimination of approximately 560 jobs and a corresponding reduction in the Company’s workforce.  The Company accrued certain employee separation costs, plant clean up, and other exit costs.  In total, impairments, accrued costs, and other valuation adjustments amounted to $55.3 million in the third and fourth quarters of 2007

 

16



 

with an additional $12.0 million recorded in the first quarter of 2008.  Probable future cash expenditures will amount to $40.0 million. The Company expects that the majority of these costs will be paid out by the end of 2008.

 

Selected information related to the restructuring accrual is as follows, with 2008 activity translated into dollars at the March 31, 2008 exchange rate:

 

Total restructuring accrual at December 31, 2007

 

$

55.3

 

Net cash paid, principally severance and related benefits

 

(1.7

)

Additional charges

 

12.0

 

Other, principally foreign exchange translation

 

(0.8

)

Remaining restructuring accrual as of March 31, 2008

 

$

64.8

 

 

During the second quarter of 2005, the Company concluded its evaluation of acquired capacity in connection with the acquisition of BSN Glasspack S.A. and announced the permanent closing of its Düsseldorf, Germany glass container factory, and the shutdown of a furnace at its Reims, France glass container facility, both in 2005.  These actions were part of the European integration strategy to optimally align the manufacturing capacities with the market and improve operational efficiencies.  As a result, the Company recorded an accrual of €47.1 million through an adjustment to goodwill.

 

These actions resulted in the elimination of approximately 400 jobs and a corresponding reduction in the Company’s workforce.  The Company anticipates that it will pay a total of approximately €110.9 million in cash related to severance, benefits, plant clean-up, and other plant closing costs related to restructuring accruals.

 

The European restructuring accrual recorded in the second quarter of 2005 was in addition to the initial estimated accrual of €63.8 million recorded in 2004. Selected information related to the restructuring accrual is as follows, with 2008 activity translated from Euros into dollars at the March 31, 2008 exchange rate:

 

Total European restructuring accrual (€110.9 million)

 

$

134.1

 

Net cash paid, principally severance and related benefits

 

(41.0

)

Other, principally foreign exchange translation

 

(12.2

)

Remaining European restructuring accrual as of December 31, 2005

 

80.9

 

Net cash paid, principally severance and related benefits

 

(33.7

)

Partial reversal of accrual (goodwill adjustment)

 

(7.6

)

Other, principally foreign exchange translation

 

(1.5

)

Remaining European restructuring accrual as of December 31, 2006

 

38.1

 

Net cash paid, principally severance and related benefits

 

(17.8

)

Other, principally foreign exchange translation

 

7.4

 

Remaining European restructuring accrual as of December 31, 2007

 

27.7

 

Net cash paid, principally severance and related benefits

 

(2.4

)

Other, principally foreign exchange translation

 

0.8

 

Remaining European restructuring accrual as of March 31, 2008

 

$

26.1

 

 

17



 

11.  Pensions

 

The components of the net periodic pension (income) cost for the three months ended March 31, 2008 and 2007 were as follows:

 

 

 

2008

 

2007

 

Service cost

 

$

12.1

 

$

13.9

 

Interest cost

 

55.1

 

52.3

 

Expected asset return

 

(81.1

)

(78.0

)

 

 

 

 

 

 

Amortization:

 

 

 

 

 

Loss

 

7.7

 

11.5

 

Prior service credit

 

(0.2

)

(0.2

)

Net amortization

 

7.5

 

11.3

 

Net periodic pension (income) cost

 

$

(6.4

)

$

(0.5

)

 

 

 

 

 

 

 

 

Total for continuing operations

 

$

(6.4

)

$

0.1

 

Total for discontinued operations

 

 

 

(0.6

)

 

 

$

(6.4

)

$

(0.5

)

 

12.  Postretirement Benefits Other Than Pensions

 

The components of the net postretirement benefit cost for the three months ended March 31, 2008 and 2007 were as follows:

 

 

 

2008

 

2007

 

Service cost

 

$

0.6

 

$

0.8

 

Interest cost

 

4.3

 

4.3

 

 

 

 

 

 

 

Amortization:

 

 

 

 

 

Prior service credit

 

(0.8

)

(1.0

)

Loss

 

1.6

 

1.6

 

Net amortization

 

0.8

 

0.6

 

Net postretirement benefit cost

 

$

5.7

 

$

5.7

 

 

 

 

 

 

 

 

 

Total for continuing operations

 

$

5.7

 

$

4.9

 

Total for discontinued operations

 

 

 

0.8

 

 

 

$

5.7

 

$

5.7

 

 

13. New Accounting Standards

 

In December 2007, the FASB issued Statement of Financial Accounting Standards No. 141R, “Business Combinations” (“FAS No. 141R”).  FAS No. 141R establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquiree and recognizes and measures the goodwill acquired in the business combination or a gain from a bargain purchase.  FAS No. 141R also sets forth the disclosures required to be made in the financial statements to evaluate the nature and financial effects of the business

 

18



 

combination.  SFAS No. 141R applies prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008.  Accordingly, FAS No. 141R will be applied by the Company to business combinations occurring on or after January 1, 2009.

 

In December 2007, the FASB issued Statement of Financial Accounting Standards No. 160, “Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51” (“FAS No. 160”).  FAS No. 160 establishes accounting and reporting standards for the non-controlling interest in a subsidiary and the deconsolidation of a subsidiary.  FAS No. 160 is effective for years beginning on or after December 15, 2008.  Adoption of FAS No. 160 is not presently expected to have a material impact on the Company’s results of operations, financial position or cash flows.

 

In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161, “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133” (“FAS No. 161”).  FAS No. 161 is intended to improve financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity’s financial condition, financial performance, and cash flows. FAS No. 161 is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008.  Adoption of FAS No. 161 is not presently expected to have a material impact on the Company’s results of operations, financial position or cash flows.

 

14. Discontinued Operations

 

On June 11, 2007, the Company announced that it had concluded the strategic review process of its plastics portfolio and entered into a definitive agreement with Rexam PLC to sell its plastics packaging business.  On July 31, 2007, the Company completed the sale for approximately $1.825 billion in cash.

 

Included in the sale were 19 plastics manufacturing plants in the U.S. (including Puerto Rico), Mexico, Brazil, Hungary, Singapore and Malaysia.  The plastics packaging business is comprised of HealthCare Packaging and Closure & Specialty Products which design, manufacture and sell plastic packaging solutions for companies in the pharmaceutical, healthcare, food and beverage, personal care, household and automotive industries.  The plastics packaging business comprised the Company’s former Plastics Packaging segment.

 

As required by FAS No. 144, the Company has presented the results of operations for the plastics packaging business in the Condensed Consolidated Results of Operations for the three months ended March 31, 2007 as discontinued operations.  Interest expense was allocated to the discontinued operations based on debt that was required by an amendment to the Agreement to be repaid from the net proceeds.  At March 31, 2007, the assets and liabilities of the plastics packaging business are presented in the Condensed Consolidated Balance Sheet as the assets and liabilities of discontinued operations.

 

The following summarizes the revenues and expenses of the discontinued operations as reported in the consolidated results of operations for the period indicated:

 

19



 

 

 

Three months

 

 

 

ended

 

 

 

March 31,

 

 

 

2007

 

Net sales

 

$

188.3

 

Manufacturing, shipping, and delivery

 

(144.3

)

Gross profit

 

44.0

 

Selling and administrative expense

 

(8.2

)

Research, development, and engineering expense

 

(3.8

)

Interest expense

 

(33.9

)

Other expense

 

(0.4

)

Losses before item below

 

(2.3

)

Credit for income taxes

 

0.2

 

 

 

 

 

Net loss from discontinued operations

 

$

(2.1

)

 

The gain on sale of discontinued operations of $4.1 million reported in 2008 relates to an adjustment of the 2007 gain on the sale of the plastics packaging business mainly related to finalizing certain tax allocations and resolution of the selling price in accordance with the final contract.

 

The condensed consolidated balance sheet at March 31, 2007 included the following assets and liabilities related to the discontinued operations:

 

 

 

Balance at

 

 

 

March 31,

 

 

 

2007

 

Assets:

 

 

 

Inventories

 

$

69.2

 

Accounts receivable

 

52.5

 

Other current assets

 

1.0

 

Total current assets

 

122.7

 

Goodwill

 

215.5

 

Other long-term assets

 

42.7

 

Net property, plant, and equipment

 

324.0

 

Total assets

 

$

704.9

 

 

 

 

 

 

Liabilities:

 

 

 

Accounts payable and other current liabilities

 

$

75.0

 

Other long-term liabilities

 

8.2

 

Total liabilities

 

$

83.2

 

 

15. Convertible Preferred Stock

 

On February 29, 2008, the Company announced that all outstanding shares of convertible preferred stock would be redeemed on March 31, 2008, if not converted by holders prior to that date.  All conversions and redemptions were completed by March 31 through the issuance of 8,584,479 shares of common stock. The conversions and redemptions resulted in an increase in common stock and capital in excess of par value totaling approximately $450 million.

 

20



 

16. Fair Value Measurements

 

In September 2006, the FASB issued Statement of Financial Accounting Standards No. 157 “Fair Value Measurements” (FAS No. 157) which defines fair value, establishes a framework for measuring fair value and enhances disclosure about fair value measurements.  On February 2, 2008, the FASB issued FASB Staff Position No. 157-2 (FSP 157-2) which delays the effective date of FAS No. 157 for nonfinancial assets and nonfinancial liabilities, except for items that are recognized or disclosed at fair value in the financial statements on least an annual basis.  Where the measurement objective specifically requires the use of “fair value” the Company has adopted the provisions of FAS No. 157 related to financial assets and financial liabilities as of January 1, 2008.  The adoption of FAS No. 157 had no impact on the Company.

 

FAS No. 157 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants.  FAS No. 157 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs for which there is little or no market data, which requires the Company to develop assumptions.

 

The Company’s derivative assets and liabilities consist of interest rate swaps, natural gas forwards, and foreign exchange option and forward contracts.  The Company uses an income approach to valuing these contracts.  Interest rate yield curves, natural gas forward rates, and foreign exchange rates are the significant inputs into the valuation models.  These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies the $17.6 million net derivative asset as Level 2 in the hierarchy.

 

The Company adopted Statement of Financial Accounting Standards No. 159 “The Fair Value Option for Financial Assets and Financial Liabilities-Including an Amendment of FASB Statement No. 115” (“FAS No. 159”) effective January 1, 2008.  This standard permits entities to choose to measure many financial instruments and certain other items at fair value.  While FAS No. 159 became effective January 1, 2008, The Company did not elect the fair value measurement option for any of our financial assets or liabilities.

 

17.  Financial Information for Subsidiary Guarantors and Non-Guarantors

 

The following presents condensed consolidating financial information for the Company, segregating:  (1) Owens-Illinois, Inc., the issuer of three series of senior notes and debentures (the “Parent”); (2) the two subsidiaries which have guaranteed the senior notes and debentures on a subordinated basis (the “Guarantor Subsidiaries”); and (3) all other subsidiaries (the “Non-Guarantor Subsidiaries”).  The Guarantor Subsidiaries are 100% owned direct and indirect subsidiaries of the Company and their guarantees are full, unconditional and joint and several.  They have no operations and function only as intermediate holding companies.

 

100% owned subsidiaries are presented on the equity basis of accounting.  Certain reclassifications have been made to conform all of the financial information to the financial

 

21



 

presentation on a consolidated basis.  The principal eliminations relate to investments in subsidiaries and intercompany balances and transactions.

 

 

 

March 31, 2008

 

 

 

 

 

 

 

Non-

 

 

 

 

 

 

 

 

 

Guarantor

 

Guarantor

 

 

 

 

 

Balance Sheet

 

Parent

 

Subsidiaries

 

Subsidiaries

 

Eliminations

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

$

 

$

 

$

1,320.6

 

$

 

$

1,320.6

 

Inventories

 

 

 

 

 

1,222.4

 

 

 

1,222.4

 

Other current assets

 

 

 

 

 

571.8

 

 

 

571.8

 

Total current assets

 

 

 

3,114.8

 

 

3,114.8

 

Investments in and advances to subsidiaries

 

3,664.1

 

2,914.1

 

 

 

(6,578.2

)

 

Goodwill

 

 

 

 

 

2,522.2

 

 

 

2,522.2

 

Other non-current assets

 

 

 

 

 

1,325.2

 

 

 

1,325.2

 

Total other assets

 

3,664.1

 

2,914.1

 

3,847.4

 

(6,578.2

)

3,847.4

 

Property, plant, and equipment, net

 

 

 

 

 

2,995.2

 

 

 

2,995.2

 

Total assets

 

$

3,664.1

 

$

2,914.1

 

$

9,957.4

 

$

(6,578.2

)

$

9,957.4

 

Current liabilities :

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

 

$

 

$

1,635.4

 

$

 

$

1,635.4

 

Current portion of asbestos liability

 

210.0

 

 

 

 

 

 

 

210.0

 

Short-term loans and long-term debt due within one year

 

250.0

 

 

 

835.1

 

(250.0

)

835.1

 

Total current liabilities

 

460.0

 

 

2,470.5

 

(250.0

)

2,680.5

 

Long-term debt

 

504.7

 

 

 

3,187.8

 

(500.0

)

3,192.5

 

Asbestos-related liabilities

 

205.3

 

 

 

 

 

 

 

205.3

 

Other non-current liabilities and minority interests

 

(4.7

)

 

 

1,385.0

 

 

 

1,380.3

 

Capital structure

 

2,498.8

 

2,914.1

 

2,914.1

 

(5,828.2

)

2,498.8

 

Total liabilities and share owners’ equity

 

$

3,664.1

 

$

2,914.1

 

$

9,957.4

 

$

(6,578.2

)

$

9,957.4

 

 

22



 

 

 

December 31, 2007

 

 

 

 

 

 

 

Non-

 

 

 

 

 

 

 

 

 

Guarantor

 

Guarantor

 

 

 

 

 

Balance Sheet

 

Parent

 

Subsidiaries

 

Subsidiaries

 

Eliminations

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

$

 

$

 

$

1,185.6

 

$

 

$

1,185.6

 

Inventories

 

 

 

 

 

1,020.8

 

 

 

1,020.8

 

Other current assets

 

 

 

 

 

488.2

 

 

 

488.2

 

Total current assets

 

 

 

2,694.6

 

 

2,694.6

 

Investments in and advances to subsidiaries

 

3,392.9

 

2,642.9

 

 

 

(6,035.8

)

 

Goodwill

 

 

 

 

 

2,428.1

 

 

 

2,428.1

 

Other non-current assets

 

 

 

 

 

1,251.9

 

 

 

1,251.9

 

Total other assets

 

3,392.9

 

2,642.9

 

3,680.0

 

(6,035.8

)

3,680.0

 

Property, plant, and equipment, net

 

 

 

 

 

2,950.0

 

 

 

2,950.0

 

Total assets

 

$

3,392.9

 

$

2,642.9

 

$

9,324.6

 

$

(6,035.8

)

$

9,324.6

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities :

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

 

$

 

$

1,618.6

 

$

 

$

1,618.6

 

Current portion of asbestos liability

 

210.0

 

 

 

 

 

 

 

210.0

 

Short-term loans and long-term debt due within one year

 

250.0

 

 

 

700.9

 

(250.0

)

700.9

 

Total current liabilities

 

460.0

 

 

2,319.5

 

(250.0

)

2,529.5

 

Long-term debt

 

500.3

 

 

 

3,013.2

 

(500.0

)

3,013.5

 

Asbestos-related liabilities

 

245.5

 

 

 

 

 

 

 

245.5

 

Other non-current liabilities and minority interests

 

(0.3

)

 

 

1,349.0

 

 

 

1,348.7

 

Capital structure

 

2,187.4

 

2,642.9

 

2,642.9

 

(5,285.8

)

2,187.4

 

Total liabilities and share owners’ equity

 

$

3,392.9

 

$

2,642.9

 

$

9,324.6

 

$

(6,035.8

)

$

9,324.6

 

 

23



 

 

 

March 31, 2007

 

 

 

 

 

 

 

Non-

 

 

 

 

 

 

 

 

 

Guarantor

 

Guarantor

 

 

 

 

 

Balance Sheet

 

Parent

 

Subsidiaries

 

Subsidiaries

 

Eliminations

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

$

 

$

 

$

1,130.9

 

$

 

$

1,130.9

 

Inventories

 

 

 

 

 

1,072.5

 

 

 

1,072.5

 

Other current assets

 

 

 

 

 

378.2

 

 

 

378.2

 

Assets of discontinued operations

 

 

 

 

 

122.7

 

 

 

122.7

 

Total current assets

 

 

 

2,704.3

 

 

2,704.3

 

Investments in and advances to subsidiaries

 

2,186.1

 

1,136.1

 

 

 

(3,322.2

)

 

Goodwill

 

 

 

 

 

2,276.0

 

 

 

2,276.0

 

Other non-current assets

 

 

 

 

 

1,202.8

 

 

 

1,202.8

 

Assets of discontinued operations

 

 

 

 

 

582.2

 

 

 

582.2

 

Total other assets

 

2,186.1

 

1,136.1

 

4,061.0

 

(3,322.2

)

4,061.0

 

Property, plant, and equipment, net

 

 

 

 

 

2,834.1

 

 

 

2,834.1

 

Total assets

 

$

2,186.1

 

$

1,136.1

 

$

9,599.4

 

$

(3,322.2

)

$

9,599.4

 

Current liabilities :

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

 

$

 

$

1,392.6

 

$

 

$

1,392.6

 

Current portion of asbestos liability

 

149.0

 

 

 

 

 

 

 

149.0

 

Short-term loans and long-term debt due within one year

 

300.0

 

 

 

550.4

 

(300.0

)

550.4

 

Liabilities of discontinued operations

 

 

 

 

 

75.0

 

 

 

75.0

 

Total current liabilities

 

449.0

 

 

2,018.0

 

(300.0

)

2,167.0

 

Liabilities of discontinued operations

 

 

 

 

 

8.2

 

 

 

8.2

 

Long-term debt

 

743.7

 

 

 

5,109.7

 

(750.0

)

5,103.4

 

Asbestos-related liabilities

 

497.7

 

 

 

 

 

 

 

497.7

 

Other non-current liabilities and minority interests

 

6.3

 

 

 

1,327.4

 

 

 

1,333.7

 

Capital structure

 

489.4

 

1,136.1

 

1,136.1

 

(2,272.2

)

489.4

 

Total liabilities and share owners’ equity

 

$

2,186.1

 

$

1,136.1

 

$

9,599.4

 

$

(3,322.2

)

$

9,599.4

 

 

24



 

 

 

Three months ended March 31, 2008

 

 

 

 

 

 

 

Non-

 

 

 

 

 

 

 

 

 

Guarantor

 

Guarantor

 

 

 

 

 

Results of Operations

 

Parent

 

Subsidiaries

 

Subsidiaries

 

Eliminations

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

 

$

 

$

1,960.5

 

$

 

$

1,960.5

 

Manufacturing, shipping, and delivery

 

 

 

 

 

(1,503.7

)

 

 

(1,503.7

)

Gross profit

 

 

 

456.8

 

 

456.8

 

Research, engineering, selling, administrative, and other

 

 

 

 

 

(163.8

)

 

 

(163.8

)

External interest expense

 

(14.4

)

 

 

(49.9

)

 

 

(64.3

)

Intercompany interest expense

 

 

 

(14.4

)

(14.4

)

28.8

 

 

External interest income

 

 

 

 

 

8.7

 

 

 

8.7

 

Intercompany interest income

 

14.4

 

14.4

 

 

 

(28.8

)

 

Equity earnings from subsidiaries

 

174.0

 

174.0

 

 

 

(348.0

)

 

Other equity earnings

 

 

 

 

 

11.1

 

 

 

11.1

 

Other revenue

 

 

 

 

 

6.6

 

 

 

6.6

 

Earnings from continuing operations before items below

 

174.0

 

174.0

 

255.1

 

(348.0

)

255.1

 

Provision for income taxes

 

 

 

 

 

(64.9

)

 

 

(64.9

)

Minority share owners’ interests in earnings of subsidiaries

 

 

 

 

 

(16.2

)

 

 

(16.2

)

Earnings from continuing operations

 

174.0

 

174.0

 

174.0

 

(348.0

)

174.0

 

Gain on sale of discontinued operations

 

4.1

 

4.1

 

4.1

 

(8.2

)

4.1

 

Net earnings

 

$

178.1

 

$

178.1

 

$

178.1

 

$

(356.2

)

$

178.1

 

 

25



 

 

 

Three months ended March 31, 2007

 

 

 

 

 

 

 

Non-

 

 

 

 

 

 

 

 

 

Guarantor

 

Guarantor

 

 

 

 

 

Results of Operations

 

Parent

 

Subsidiaries

 

Subsidiaries

 

Eliminations

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

 

$

 

$

1,684.0

 

$

 

$

1,684.0

 

Manufacturing, shipping, and delivery

 

 

 

 

 

(1,356.2

)

 

 

(1,356.2

)

Gross profit

 

 

 

327.8

 

 

327.8

 

Research, engineering, selling, administrative, and other

 

 

 

 

 

(158.4

)

 

 

(158.4

)

External interest expense

 

(20.6

)

 

 

(60.4

)

 

 

(81.0

)

Intercompany interest expense

 

 

 

(20.6

)

(20.6

)

41.2

 

 

External interest income

 

 

 

 

 

3.4

 

 

 

3.4

 

Intercompany interest income

 

20.6

 

20.6

 

 

 

(41.2

)

 

Equity earnings from subsidiaries

 

55.3

 

55.3

 

 

 

(110.6

)

 

Other equity earnings

 

 

 

 

 

5.1

 

 

 

5.1

 

Other revenue

 

 

 

 

 

8.5

 

 

 

8.5

 

Earnings from continuing operations before items below

 

55.3

 

55.3

 

105.4

 

(110.6

)

105.4

 

Provision for income taxes

 

 

 

 

 

(38.6

)

 

 

(38.6

)

Minority share owners’ interests in earnings of subsidiaries

 

 

 

 

 

(11.5

)

 

 

(11.5

)

Earnings from continuing operations

 

55.3

 

55.3

 

55.3

 

(110.6

)

55.3

 

Net losses of discontinued operations

 

(2.1

)

(2.1

)

(2.1

)

4.2

 

(2.1

)

Net earnings

 

$

53.2

 

$

53.2

 

$

53.2

 

$

(106.4

)

$

53.2

 

 

26



 

 

 

Three months ended March 31, 2008

 

 

 

 

 

 

 

Non-

 

 

 

 

 

 

 

 

 

Guarantor

 

Guarantor

 

 

 

 

 

Cash Flows

 

Parent

 

Subsidiaries

 

Subsidiaries

 

Eliminations

 

Consolidated

 

Cash provided by (used in) operating activities

 

$

(40.2

)

$

 

$

60.9

 

$

 

$

20.7

 

Cash used in investing activities

 

 

 

 

 

(77.0

)

 

 

(77.0

)

Cash provided by financing activities

 

40.2

 

 

 

99.2

 

 

 

139.4

 

Effect of exchange rate change on cash

 

 

 

 

 

12.2

 

 

 

12.2

 

Net change in cash

 

 

 

95.3

 

 

95.3

 

Cash at beginning of period

 

 

 

 

 

387.7

 

 

 

387.7

 

Cash at end of period

 

$

 

$

 

$

483.0

 

$

 

$

483.0

 

 

 

 

Three months ended March 31, 2007

 

 

 

 

 

 

 

Non-

 

 

 

 

 

 

 

 

 

Guarantor

 

Guarantor

 

 

 

 

 

Cash Flows

 

Parent

 

Subsidiaries

 

Subsidiaries

 

Eliminations

 

Consolidated

 

Cash used in operating activities

 

$

(41.0

)

$

 

$

(3.1

)

$

 

$

(44.1

)

Cash used in investing activities

 

 

 

 

 

(46.1

)

 

 

(46.1

)

Cash provided by financing activities

 

41.0

 

 

 

116.2

 

 

 

157.2

 

Effect of exchange rate change on cash

 

 

 

 

 

4.0

 

 

 

4.0

 

Net change in cash

 

 

 

71.0

 

 

71.0

 

Cash at beginning of period

 

 

 

 

 

222.7

 

 

 

222.7

 

Cash at end of period

 

$

 

$

 

$

293.7

 

$

 

$

293.7

 

 

27



 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Executive Overview

 

Quarters ended March 31, 2008 and 2007

 

Net sales from continuing operations were $276.5 million higher than the prior year principally resulting from improved pricing, product mix, and favorable foreign currency exchange rates, partially offset by decreased sales volume.

 

Segment Operating Profit for reportable segments was $112.1 million higher than the prior year.  The benefits of product mix, higher selling prices and favorable exchange rates were partially offset by inflationary cost increases and decreased unit shipments.

 

Interest expense for the first quarter of 2008 was $64.3 million compared to $81.0 million from continuing operations for the first quarter of 2007. The decrease was due to lower debt levels, lower variable interest rates under the Company’s bank credit agreement, and fixed to floating swaps.

 

Net earnings from continuing operations for 2008 were $174.0 million, or $1.02 per share (diluted), compared to $55.3 million, or $0.31 per share (diluted) for 2007.  Earnings in 2008 included items that management considered not representative of ongoing operations. These items decreased net earnings in 2008 by $9.7 million, or $0.06 per share.

 

Cash payments for asbestos-related costs were $40.2 million for 2008 compared to $41.0 million for 2007.

 

Capital spending for property, plant, and equipment for continuing operations was $45.4 million for 2008 compared to $32.6 million for 2007.

 

Results of Operations – First Quarter of 2008 compared with First Quarter of 2007

 

Net Sales

 

The Company’s net sales by segment for the first quarter of 2008 and 2007 are presented in the following table.  For further information, see Segment Information included in Note 7 to the Condensed Consolidated Financial Statements.

 

 

 

2008

 

2007

 

 

 

(dollars in millions)

 

Europe

 

$

888.9

 

$

728.4

 

North America

 

530.9

 

523.4

 

South America

 

254.2

 

203.2

 

Asia Pacific

 

250.0

 

212.5

 

Reportable segment totals

 

1,924.0

 

1,667.5

 

Other

 

36.5

 

16.5

 

Consolidated totals

 

$

1,960.5

 

$

1,684.0

 

 

28



 

The Company’s net sales for the first quarter of 2008 increased $276.5 million, or 16.4%, over the first quarter of 2007.

 

The change in net sales for reportable segments can be summarized as follows (dollars in millions):

 

Net sales - 2007

 

 

 

$

1,667.5

 

Effects of changing foreign currency rates

 

$

187.0

 

 

 

Net effect of price and mix

 

119.0

 

 

 

Decreased sales volume

 

(49.5

)

 

 

Total effect on net sales

 

 

 

256.5

 

Net sales - 2008

 

 

 

$

1,924.0

 

 

Segment Operating Profit

 

Operating Profit for the reportable segments in the table below includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided.  Unallocated corporate expenses and certain other expenses not directly related to the reportable segments’ operations are included in Retained Corporate Costs and Other.  For further information, see Segment Information included in Note 7 to the Condensed Consolidated Financial Statements.

 

 

 

2008

 

2007

 

 

 

(dollars in millions)

 

Europe

 

$

147.6

 

$

74.8

 

North America

 

55.5

 

62.5

 

South America

 

73.6

 

48.0

 

Asia Pacific

 

45.4

 

24.7

 

Reportable segment totals

 

322.1

 

210.0

 

Retained corporate costs and other

 

1.5

 

(27.0

)

Consolidated totals

 

$

323.6

 

$

183.0

 

 

Segment Operating Profit for reportable segments for the first quarter of 2008 increased $112.1 million, or 53.4%, to $322.1 million, compared with Segment Operating Profit of $210.0 million for the first quarter of 2007.

 

The change in Segment Operating Profit for reportable segments can be summarized as follows (dollars in millions):

 

Segment Operating Profit - 2007

 

 

 

$

210.0

 

Net effect of price and mix

 

$

119.0

 

 

 

Effects of changing foreign currency rates

 

35.0

 

 

 

Manufacturing and delivery

 

(55.0

)

 

 

Decreased sales volume

 

(12.0

)

 

 

Other

 

25.1

 

 

 

Total net effect on Segment Operating Profit

 

 

 

112.1

 

Segment Operating Profit - 2008

 

 

 

$

322.1

 

 

29



 

Retained corporate costs and other for 2008 was income of $1.5 million compared with expense of $27.0 million for 2007. Beginning in 2008, the Company revised its method of allocating corporate expenses.  The Company decreased slightly the percentage allocation based on sales and significantly expanded the number of functions included in the allocation based on cost of services.  It is not practicable to quantify the net effect of these changes on periods prior to 2008.  However, the effect for 2008 was to reduce the amount of retained corporate costs by approximately $8 million.  Also contributing to the decrease was increased pension income for 2008 and the absence of an accrual for self-insured risks for property related losses from the first quarter of 2007.

 

Interest Expense

 

Interest expense for the first quarter of 2008 was $64.3 million compared to $81.0 million from continuing operations for the first quarter of 2007. The decrease was due to lower debt levels, lower variable interest rates under the Company’s bank credit agreement, and fixed to floating swaps.

 

Minority Share Owners’ Interest in Earnings of Subsidiaries

 

Minority share owners’ interest in earnings of subsidiaries for the first quarter of 2008 was $16.2 million compared to $11.5 million for the first quarter of 2007.  The increase is primarily attributed to higher earnings from the Company’s operations in South America.

 

Provision for Income Taxes

 

The Company’s effective tax rate for the three months ended March 31, 2008 was 25.4%, compared with 36.6% for the first three months of 2007. The reduction is principally due to:  (1) a change in mix of earnings to jurisdictions where the Company is subject to lower effective rates, and (2) the effect of higher earnings and lower interest costs in the U.S., where the Company has recognized a valuation allowance on net deferred tax assets.  Based upon the current projection for the mix of earnings for 2008, the Company expects that the full year effective tax rate will be slightly below the 24.4% effective tax rate for 2007.

 

Restructuring and Impairment Charges

 

During the first quarter of 2008, the Company recorded charges totaling $12.9 million ($9.7 million after tax), for additional restructuring and asset impairment in the Caribbean, Asia Pacific, Europe, and North America.  The charges reflect the additional results of the Company’s ongoing global profitability review.  See Note 10 for additional information.

 

Discontinued Operations

 

On June 11, 2007, the Company announced that it had concluded the strategic review process of its plastics portfolio and entered into a definitive agreement with Rexam PLC to sell its plastics packaging business.  On July 31, 2007, the Company completed the sale for approximately $1.825 billion in cash.

 

Included in the sale were 19 plastics manufacturing plants in the U.S. (including Puerto Rico), Mexico, Brazil, Hungary, Singapore and Malaysia.  The plastics packaging business is comprised of HealthCare Packaging and Closure & Specialty Products which design, manufacture and sell plastic packaging solutions for companies in the pharmaceutical,

 

30



 

healthcare, food and beverage, personal care, household and automotive industries.  The plastics packaging business comprised the Company’s former Plastics Packaging segment.

 

As required by FAS No. 144, the Company has presented the results of operations for the plastics packaging business in the Condensed Consolidated Results of Operations for the three months ended March 31, 2007 as discontinued operations.  Interest expense was allocated to the discontinued operations based on debt that was required by an amendment to the Secured Credit Agreement to be repaid from the net proceeds.  At March 31, 2007, the assets and liabilities of the plastics packaging business are presented in the Condensed Consolidated Balance Sheet as the assets and liabilities of discontinued operations.

 

The following summarizes the revenues and expenses of the discontinued operations as reported in the consolidated results of operations for the period indicated:

 

 

 

Three months
ended
March 31,
2007

 

Net sales

 

$

188.3

 

Manufacturing, shipping, and delivery

 

(144.3

)

Gross profit

 

44.0

 

Selling and administrative expense

 

(8.2

)

Research, development, and engineering expense

 

(3.8

)

Interest expense

 

(33.9

)

Other expense

 

(0.4

)

Losses before item below

 

(2.3

)

Credit for income taxes

 

0.2

 

 

 

 

 

Net loss from discontinued operations

 

$

(2.1 

)

 

The gain on sale of discontinued operations of $4.1 million reported in 2008 relates to an adjustment of the 2007 gain on the sale of the plastics packaging business mainly related to finalizing certain tax allocations and resolution of the selling price in accordance with the final contract.

 

The condensed consolidated balance sheet at March 31, 2007 included the following assets and liabilities related to the discontinued operations:

 

31



 

 

 

Balance at

 

 

 

March 31,

 

 

 

2007

 

Assets:

 

 

 

Inventories

 

$

69.2

 

Accounts receivable

 

52.5

 

Other current assets

 

1.0

 

Total current assets

 

122.7

 

Goodwill

 

215.5

 

Other long-term assets

 

42.7

 

Net property, plant, and equipment

 

324.0

 

Total assets

 

$

704.9

 

 

 

 

 

Liabilities:

 

 

 

Accounts payable and other current liabilities

 

$

75.0

 

Other long-term liabilities

 

8.2

 

Total liabilities

 

$

83.2

 

 

Capital Resources and Liquidity

 

The Company's total debt at March 31, 2008 was $4.03 billion, compared to $3.71 billion at December 31, 2007 and $5.65 billion at March 31, 2007. 

 

On June 14, 2006, the Company’s subsidiary borrowers entered into the secured credit agreement (the “Agreement”).  At March 31, 2008, the Agreement included a $900.0 million revolving credit facility, a 225.0 million Australian dollar term loan, and a 110.8 million Canadian dollar term loan, each of which has a final maturity date of June 15, 2012. It also included a $191.5 million term loan and a €191.5 million term loan, each of which has a final maturity date of June 14, 2013.

 

At March 31, 2008 the Company’s subsidiary borrowers had unused credit of $725.6 million available under the Agreement.

 

The weighted average interest rate on borrowings outstanding under the Agreement at March 31, 2008 was 6.08%.

 

During March 2007, a subsidiary of the Company issued Senior Notes totaling €300.0 million.  The notes bear interest at 6.875% and are due March 31, 2017.  The notes are guaranteed by substantially all of the Company’s domestic subsidiaries.  The proceeds were used to retire the $300 million principal amount of 8.10% Senior Notes which matured in May 2007, and to reduce borrowings under the revolving credit facility.  

 

Information related to the Company’s accounts receivable securitization program is as follows:

 

32



 

 

 

March 31,

 

Dec. 31,

 

March 31,

 

 

 

2008

 

2007

 

2007

 

 

 

 

 

 

 

 

 

Balance (included in short-term loans)

 

$

439.6

 

$

361.8

 

$

229.2

 

 

 

 

 

 

 

 

 

Weighted average interest rate

 

6.10

%

5.48

%

5.61

%

 

Cash provided by continuing operating activities in the first three months of 2008 was $20.7 million compared with a use of $40.2 million in the prior year. The increase is mainly attributable to improved earnings, partially offset by a larger seasonal increase in working capital.

 

Capital spending for property, plant, and equipment was $45.4 million in the first three months of 2008 compared with $32.6 million (continuing operations) in the prior year.  In addition, during 2007, the Company capitalized $4.1 million under capital lease obligations with the related financing recorded as long term debt.

 

The Company anticipates that cash flow from its operations and from utilization of credit available under the Agreement will be sufficient to fund its operating and seasonal working capital needs, debt service and other obligations on a short-term and long-term basis.  Based on the Company’s expectations regarding future payments for lawsuits and claims and also based on the Company’s expected operating cash flow, the Company believes that the payment of any deferred amounts of previously settled or otherwise determined lawsuits and claims, and the resolution of presently pending and anticipated future lawsuits and claims associated with asbestos, will not have a material adverse effect upon the Company’s liquidity on a short-term or long-term basis.

 

Critical Accounting Estimates

 

The Company’s analysis and discussion of its financial condition and results of operations are based upon its consolidated financial statements that have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).  The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities.  The Company evaluates these estimates and assumptions on an ongoing basis.  Estimates and assumptions are based on historical and other factors believed to be reasonable under the circumstances at the time the financial statements are issued.  The results of these estimates may form the basis of the carrying value of certain assets and liabilities and may not be readily apparent from other sources.  Actual results, under conditions and circumstances different from those assumed, may differ from estimates.

 

The impact of, and any associated risks related to, estimates and assumptions are discussed within Management’s Discussion and Analysis of Financial Condition and Results of Operations, as well as in the Notes to the Consolidated Financial Statements, if applicable, where estimates and assumptions affect the Company’s reported and expected financial results.

 

The Company believes that accounting for property, plant and equipment, impairment of long-lived assets, pension benefit plans, contingencies and litigation, and income taxes involves the

 

33



 

more significant judgments and estimates used in the preparation of its consolidated financial statements.

 

Property, Plant, and Equipment

 

The net carrying amount of property, plant, and equipment (“PP&E”) at March 31, 2008 totaled $2,995.2 million, representing 30% of total assets.  Depreciation expense for the three months ended March 31, 2008 totaled $113.6 million, representing over 6% of total costs and expenses. Given the significance of PP&E and associated depreciation to the Company’s consolidated financial statements, the determinations of an asset’s cost basis and its economic useful life are considered to be critical accounting estimates.

 

Cost Basis - PP&E is recorded at cost, which is generally objectively quantifiable when assets are purchased individually.   However, when assets are purchased in groups, or as part of a business, costs assigned to PP&E are based on an estimate of fair value of each asset at the date of acquisition.  These estimates are based on assumptions about asset condition, remaining useful life and market conditions, among others.  The Company frequently employs expert appraisers to aid in allocating cost among assets purchased as a group.

 

Included in the cost basis of PP&E are those costs which substantially increase the useful lives or capacity of existing PP&E.  Significant judgment is needed to determine which costs should be capitalized under these criteria and which costs should be expensed as a repair or maintenance expenditure.  For example, the Company frequently incurs various costs related to its existing glass melting furnaces and forming machines and must make a determination of which costs, if any, to capitalize.  The Company relies on the experience and expertise of its operations and engineering staff to make reasonable and consistent judgments regarding increases in useful lives or capacity of PP&E.

 

Estimated Useful Life – PP&E is generally depreciated using the straight-line method, which deducts equal amounts of the cost of each asset from earnings each period over its estimated economic useful life.  Economic useful life is the duration of time an asset is expected to be productively employed by the Company, which may be less than its physical life. Management’s assumptions regarding the following factors, among others, affect the determination of estimated economic useful life: wear and tear, product and process obsolescence, technical standards, and changes in market demand.

 

The estimated economic useful life of an asset is monitored to determine its appropriateness, especially in light of changed business circumstances. For example, technological advances, excessive wear and tear, or changes in customers’ requirements may result in a shorter estimated useful life than originally anticipated. In these cases, the Company depreciates the remaining net book value over the new estimated remaining life, thereby increasing depreciation expense per year on a prospective basis.  Likewise, if the estimated useful life is increased, the adjustment to the useful life decreases depreciation expense per year on a prospective basis.

 

Impairment of Long-Lived Assets

 

Property, Plant, and Equipment –As required by FAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” the Company tests for impairment of PP&E whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable.  PP&E held for use in the Company’s business is grouped for impairment testing at the lowest level for which cash flows can reasonably be identified, typically a geographic region.  The Company assesses recoverability by comparing the carrying amount of the asset group to

 

34



 

the estimated undiscounted future cash flows expected to be generated by the assets.  If an asset group is considered impaired, the impairment loss to be recognized is measured as the amount by which the asset group’s carrying amount exceeds its fair value.  PP&E held for sale is reported at the lower of carrying amount or fair value less cost to sell.

 

Impairment testing requires estimation of the fair value of PP&E based on the discounted value of projected future cash flows generated by the asset group.  The assumptions underlying cash flow projections represent management’s best estimates at the time of the impairment review.  Factors that management must estimate include, among other things: industry and market conditions, sales volume and prices, production costs and inflation.  Changes in key assumptions or actual conditions which differ from estimates could result in an impairment charge.  The Company uses reasonable and supportable assumptions when performing impairment reviews and cannot predict the occurrence of future events and circumstances that could result in impairment charges.

 

In mid-2007, the Company began a strategic review of its global manufacturing footprint.  The review is expected to be ongoing in 2008 and 2009.  As an initial result of this review, during the third and fourth quarters of 2007 and the first quarter of 2008, the Company recorded charges that included asset impairments in North America, the Caribbean, Asia Pacific and Europe.  It is possible that the Company may conclude in the future that it will close or temporarily idle additional selected facilities or production lines and reduce headcount to increase operating performance and cash flows.  As of March 31, 2008, no other decisions had been made and no events had occurred that would require an additional evaluation of possible impairment in accordance with FAS No. 144.  For additional information on charges recorded in 2008 and 2007, see Notes 8 and 10 to the Condensed Consolidated Financial Statements.

 

Goodwill – Goodwill at March 31, 2008 totaled $2,522.2 million, representing 25% of total assets.  As required by FAS No. 142, “Goodwill and Other Intangibles,” the Company evaluates goodwill annually (or more frequently if impairment indicators arise) for impairment.  The Company conducts its evaluation as of October 1 of each year.  Goodwill impairment testing is performed using the business enterprise value (“BEV”) of each reporting unit which is calculated as of a measurement date by determining the present value of debt-free, after-tax projected future cash flows, discounted at the weighted average cost of capital of a hypothetical third party buyer.  This BEV is then compared to the book value of each reporting unit as of the measurement date to assess whether an impairment of goodwill may exist.

 

During the fourth quarter of 2007, the Company completed its annual testing and determined that no impairment of goodwill existed.

 

The testing performed as of October 1, 2007, indicated a significant excess of BEV over book value for each unit.  However, if the Company’s projected future cash flows are substantially lower, or if the assumed weighted average cost of capital is substantially higher, future testing may indicate an impairment of one or more of the Company’s reporting units and, as a result, the related goodwill will also be impaired.

 

The Company will monitor conditions throughout 2008 that might significantly affect the projections and variables used in the impairment test to determine if a review prior to October 1 may be appropriate.  If the results of impairment testing confirm that a write down of goodwill is necessary, then the Company will record a charge in the fourth quarter of 2008, or earlier if appropriate.  In the event the Company would be required to record a significant write down of

 

35



 

goodwill, the charge would have a material adverse effect on reported results of operations and net worth.

 

Other Long-Lived Assets – Other long-lived assets include, among others, equity investments and repair parts inventories.  The Company’s equity investments are non-publicly traded ventures with other companies in businesses related to those of the Company.  Equity investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable.  In the event that a decline in fair value of an investment occurs, and the decline in value is considered to be other than temporary, an impairment loss is recognized. Summarized financial information of equity affiliates is included in Note 5 to the 2007 Annual Report on Form 10-K.  For additional information on charges recorded in 2008 and 2007, see Notes 8 and 10 to the Condensed Consolidated Financial Statements.

 

The Company carries a significant amount of repair parts inventories in order to provide a dependable supply of quality parts for servicing the Company’s PP&E, particularly its glass melting furnaces and forming machines.  The Company evaluates the recoverability of repair parts inventories based on undiscounted projected cash flows, excluding interest and taxes, when factors indicate that impairment may exist.  If impairment exists, the repair parts are written down to fair value.  The Company continually monitors the carrying value of repair parts for recoverability, especially in light of changing business circumstances.  For example, technological advances related to, and changes in, the estimated future demand for products produced on the equipment to which the repair parts relate may make the repair parts obsolete.  In these circumstances, the Company writes down the repair parts to fair value.

 

Pension Benefit Plans

 

Significant Estimates - The determination of pension obligations and the related pension expense or credits to operations involves significant estimates.  The most significant estimates are the discount rate used to calculate the actuarial present value of benefit obligations and the expected long-term rate of return on plan assets.  The Company uses discount rates based on yields of high quality fixed rate debt securities at the end of the year.  At December 31, 2007, the weighted average discount rate for all plans was 5.87%.  The Company uses an expected long-term rate of return on assets that is based on both past performance of the various plans’ assets and estimated future performance of the assets.  Due to the nature of the plans’ assets and the volatility of debt and equity markets, actual returns may vary significantly from year to year.  The Company refers to average historical returns over longer periods (up to 10 years) in determining its expected rates of return because short-term fluctuations in market values do not reflect the rates of return the Company expects to achieve based upon its long-term investing strategy.  For purposes of determining pension charges and credits in 2008, the Company’s estimated weighted average expected long-term rate of return on plan assets is 8.1%, unchanged from 2007.  The Company recorded pension income (expense) from continuing operations of $6.4 million and $(0.1) million for the three months ended March 31, 2008 and 2007, respectively, from its principal defined benefit pension plans.  Depending on currency translation rates, the Company expects to record approximately $26 million of pension income for the full year of 2008.  The expected improvement in 2008 is a result of higher asset values, principally in the U.S. plans.

 

Future effects on reported results of operations depend on economic conditions and investment performance.  For example, a one-half percentage point change in the actuarial assumption regarding the expected return on assets would result in a change of approximately $20 million in

 

36



 

the pretax pension amount for the full year 2008.  In addition, changes in external factors, including the fair values of plan assets and the discount rates used to calculate plan liabilities, could have a significant effect on the recognition of funded status as described below.

 

Recognition of Funded Status –FAS No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans”, requires employers to adjust the assets and liabilities related to defined benefit plans so that the amounts reflected on the balance sheet represent the overfunded or underfunded status of the plans.  These funded status amounts are measured as the difference between the fair value of plan assets and actuarially calculated benefit obligations as of the balance sheet date.  At December 31, 2007, the Accumulated Other Comprehensive Loss component of share owners’ equity was decreased by $79.1 million ($70.5 million after tax) to reflect a net increase in the funded status of the Company’s plans at that date.

 

Funding and Credit Compliance - The Company believes it will not be required to make cash contributions to the U.S. plans for at least several years.  The Company expects to contribute approximately $62.8 million to its non-U.S. defined benefit pension plans in 2008, compared with $63.9 million in 2007.

 

Contingencies and Litigation

 

The Company believes that its ultimate asbestos-related liability (i.e., its indemnity payments or other claim disposition costs plus related legal fees) cannot be estimated with certainty. The Company’s ability reasonably to estimate its liability has been significantly affected by the volatility of asbestos-related litigation in the United States, the expanding list of non-traditional defendants that have been sued in this litigation and found liable for substantial damage awards, the use of mass litigation screenings to generate new lawsuits, the large number of claims asserted or filed by parties who claim prior exposure to asbestos materials but have no present physical impairment as a result of such exposure, and the significant number of co-defendants that have filed for bankruptcy.  The Company continues to monitor trends which may affect its ultimate liability and continues to analyze the developments and variables affecting or likely to affect the resolution of pending and future asbestos claims against the Company.  During 2007, the Company accelerated the disposition and payment of certain claims, most of which had been accounted for previously in establishing the accrual for its asbestos liability, which acceleration resulted in a significant increase in reported filings, dispositions and cash payments during the year.  The Company expects that these accelerated dispositions will likely continue in 2008, resulting in increased cash payments during the first half of 2008 compared to the first half of 2007.

 

The Company conducts a comprehensive review of its asbestos-related liabilities and costs annually in connection with finalizing and reporting its annual results of operations, unless significant changes in trends or new developments warrant an earlier review.  If the results of an annual comprehensive review indicate that the existing amount of the accrued liability is insufficient to cover its estimated future asbestos-related costs, then the Company will record an appropriate charge to increase the accrued liability.  The Company believes that an estimation of the reasonably probable amount of the contingent liability for claims not yet asserted against the Company is not possible beyond a period of several years.  Therefore, while the results of future annual comprehensive reviews cannot be determined, the Company expects the addition of one year to the estimation period will result in an annual charge.

 

37



 

In the fourth quarter of 2007, the Company recorded a charge of $115.0 million (pretax and after tax) to increase its accrued liability for asbestos-related costs. This amount was reduced from the 2006 charge of $120.0 million.  The factors and developments that particularly affected the determination of the amount of this increase in the accrual included the following: (i) the rates of filings against the Company; (ii) the emerging evidence of irregularities associated with mass litigation screenings;  (iii) the Company’s successful litigation record during the year; (iv) the legislative developments and court rulings in several states; (iv) the Company’s strategy to accelerate settlements of certain claims on favorable terms, and (v) the impact these and other factors had on the Company’s valuation of existing and future claims.

 

The Company’s estimates are based on a number of factors as described further in Note 6 to the Condensed Consolidated Financial Statements.

 

Income Taxes

 

The Company accounts for income taxes as required by the provisions of FAS No. 109, “Accounting for Income Taxes,” under which deferred tax assets and liabilities are recognized for the tax effects of temporary differences between the financial reporting and tax bases of assets and liabilities measured using enacted tax rates.

 

The Company adopted FASB Interpretation 48, “Accounting for Uncertainty in Income Taxes,” (“FIN 48”), as of January, 1, 2007.  Management judgment is required in determining income tax expense and the related balance sheet amounts.  In addition, under FIN 48 judgments are required concerning the ultimate outcome of uncertain income tax positions.  Actual income taxes paid may vary from estimates, depending upon changes in income tax laws, actual results of operations, and the final audit of tax returns by taxing authorities. Tax assessments may arise several years after tax returns have been filed. The Company believes that its recorded tax liabilities adequately provide for the probable outcome of these assessments.

 

Deferred tax assets are also recorded for operating losses and tax credit carryforwards. However, FAS No. 109 requires that a valuation allowance be recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  This assessment is largely dependent upon projected near-term profitability including the effects of tax planning.  Deferred tax assets and liabilities are determined separately for each tax jurisdiction in which the Company conducts its operations or otherwise incurs taxable income or losses.  In the U.S., the Company has recorded significant deferred tax assets, the largest of which relate to foreign and other tax credits and the accrued liability for asbestos-related costs that are not deductible until paid.  The deferred tax assets are partially offset by deferred tax liabilities, the most significant of which relate to the prepaid pension asset and accelerated depreciation.  The Company has recorded a valuation allowance for the portion of U.S. deferred tax assets not offset by deferred tax liabilities.  During the third quarter of 2007 the Company sold its discontinued plastics operations.  For tax purposes, the gain on the sale will be substantially offset by capital and net operating loss carryforwards. The credit for the corresponding reduction in the valuation allowance of $406.8 million was classified as a component of the gain on sale of discontinued operations.  In 2007 the Company implemented a plan to restructure the ownership and intercompany obligations of certain foreign subsidiaries.  These actions resulted in taxation of a significant portion of previously unremitted foreign earnings and will transfer a portion of the Company’s debt service obligations to operations outside the U.S. in order to better balance operating cash flows with financing costs on a global basis.  The foreign earnings reported as taxable in the U.S. were offset by net operating loss carryforwards and foreign tax

 

38



 

credits.  Foreign tax credit carryforwards arising from the restructuring were fully offset by an increase in the valuation allowance.

 

Forward Looking Statements

 

This document contains “forward looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933. Forward-looking statements reflect the Company’s current expectations and projections about future events at the time, and thus involve uncertainty and risk. It is possible the Company’s future financial performance may differ from expectations due to a variety of factors including, but not limited to the following: (1) foreign currency fluctuations relative to the U.S. dollar, (2) changes in capital availability or cost, including interest rate fluctuations, (3) the general political, economic and competitive conditions in markets and countries where the Company has its operations, including disruptions in the supply chain, competitive pricing pressures, inflation or deflation, and changes in tax rates and laws, (4) consumer preferences for alternative forms of packaging, (5) fluctuations in raw material and labor costs, (6) availability of raw materials, (7) costs and availability of energy, (8) transportation costs, (9) the ability of the Company to raise selling prices commensurate with energy and other cost increases without the loss of customers or sales volume, (10) consolidation among competitors and customers, (11) the ability of the Company to integrate operations of acquired businesses and achieve expected synergies, (12) unanticipated expenditures with respect to environmental, safety and health laws, (13) the performance by customers of their obligations under purchase agreements, and (14) the timing and occurrence of events which are beyond the control of the Company, including events related to asbestos-related claims. It is not possible to foresee or identify all such factors. Any forward looking statements in this document are based on certain assumptions and analyses made by the Company in light of its experience and perception of historical trends, current conditions, expected future developments, and other factors it believes are appropriate in the circumstances. Forward-looking statements are not a guarantee of future performance and actual results or developments may differ materially from expectations. While the Company continually reviews trends and uncertainties affecting the Company’s results of operations and financial condition, the Company does not assume any obligation to update or supplement any particular forward looking statements contained in this document.

 

Item 3.    Quantitative and Qualitative Disclosure About Market Risk.

 

There have been no material changes in market risk at March 31, 2008 from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2007.

 

Item 4.    Controls and Procedures.

 

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.  In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.  Also, the Company has investments in certain unconsolidated entities.  As the

 

39



 

Company does not control or manage these entities, its disclosure controls and procedures with respect to such entities are necessarily substantially more limited than those maintained with respect to its consolidated subsidiaries.

 

As required by Rule 13a-15(b) of the Exchange Act, the Company carried out an evaluation, under the supervision and with the participation of management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report.  Based on the foregoing, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2008.

 

Management concluded that the Company’s system of internal control over financial reporting was effective as of December 31, 2007.  There has been no change in the Company’s internal controls over financial reporting during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal controls over financial reporting. The Company is undertaking the phased implementation of a global Enterprise Resource Planning software system and believes it is maintaining and monitoring appropriate internal controls during the implementation period.  The Company believes that the internal control environment will be enhanced as a result of implementation.

 

PART II – OTHER INFORMATION

 

Item 1.  Legal Proceedings.

 

For further information on legal proceedings, see Note 6 to the Condensed Consolidated Financial Statements, “Contingencies,” that is included in Part I of this Report and is incorporated herein by reference.

 

Item 1A.  Risk Factors.

 

There have been no material changes in risk factors at March 31, 2008 from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2007.

 

 

Item 6.  Exhibits.

 

Exhibit 12              Computation of Ratio of Earnings to Fixed Charges       and Earnings to Combined Fixed Charges and Preferred Stock Dividends

 

Exhibit 31.1           Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

Exhibit 31.2           Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

Exhibit 32.1*         Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350

 

Exhibit 32.2*          Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350

 

40



 


*      This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

41



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

OWENS-ILLINOIS, INC.

 

 

 

 

Date

May 9, 2008

 

By

/s/ Edward C. White

 

 

Edward C. White

 

 

Senior Vice President and Chief Financial
Officer
(Principal Financial Officer)

 

42



 

INDEX TO EXHIBITS

 

Exhibits

 

 

 

 

 

12

 

Computation of Ratio of Earnings to Fixed Charges and Earnings to Combined Fixed Charges and Preferred Stock Dividends

 

 

 

31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

31.2

 

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1*

 

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350

 

 

 

32.2*

 

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350

 


*      This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

43